Details for New Drug Application (NDA): 200166
✉ Email this page to a colleague
NDA 200166 describes EVEKEO, which is a drug marketed by Azurity and is included in two NDAs. It is available from three suppliers. There are three patents protecting this drug. Additional details are available on the EVEKEO profile page.
The generic ingredient in EVEKEO is amphetamine sulfate. There are fifty-five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the amphetamine sulfate profile page.
The generic ingredient in EVEKEO is amphetamine sulfate. There are fifty-five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the amphetamine sulfate profile page.
Summary for 200166
| Tradename: | EVEKEO |
| Applicant: | Azurity |
| Ingredient: | amphetamine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 200166
| Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 200166
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| EVEKEO | amphetamine sulfate | TABLET;ORAL | 200166 | ANDA | Azurity Pharmaceuticals, Inc. | 24338-022 | 24338-022-03 | 30 TABLET in 1 BOTTLE (24338-022-03) |
| EVEKEO | amphetamine sulfate | TABLET;ORAL | 200166 | ANDA | Azurity Pharmaceuticals, Inc. | 24338-026 | 24338-026-03 | 30 TABLET in 1 BOTTLE (24338-026-03) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Aug 9, 2012 | TE: | AA | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Aug 9, 2012 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
